A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...

Last week, the Food and Drug Administration banned Red Dye No. 3 over cancer risks. Good.

Zentalis Pharmaceuticals said it would cut 40% of its workforce as part of a restructuring to support the late-stage development of its cancer-drug azenosertib.

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

Studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity ...

These risks prompted California to ban its use in food in 2023 and the Food and Drug Administration to ban its use in both ..

A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...